MOMENTA PHARMACEUTICALS
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans. This results in a diversified product pipeline of complex generic, follow-on biologic and novel drugs. The Company's two most advanced complex generic product candidates target marketed products, which were originally approved by t... he United States Food and Drug Administration as New Drug Applications. M-Enoxaparin is designed to be a generic version of Lovenox (enoxaparin sodium injection), a low-molecular weight heparin used to prevent and treat deep vein thrombosis. Its second major generic product candidate is M356, a generic version of Copaxone (glatiramer acetate injection), a drug that is indicated for the reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis.
MOMENTA PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2001-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.momentapharma.com
Total Employee:
501+
Status:
Active
Contact:
(617)621-0431
Email Addresses:
[email protected]
Total Funding:
39.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Content Delivery Network Google Universal Analytics Domain Not Resolving Amazon
Similar Organizations
Entos Pharmaceuticals
Entos Pharmaceuticals is a healthcare biotechnology company that develops nucleic acid therapies.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-12-05 | Virdante Pharmaceuticals | Virdante Pharmaceuticals acquired by Momenta Pharmaceuticals | 51.5 M USD |
| 2007-05-10 | Parivid | Parivid acquired by Momenta Pharmaceuticals | N/A |
Investors List
Atlas Venture
Atlas Venture investment in Series C - Momenta Pharmaceuticals
Mithra Ventures
Mithra Ventures investment in Series C - Momenta Pharmaceuticals
Cardinal Partners
Cardinal Partners investment in Series C - Momenta Pharmaceuticals
MVM Life Science Partners
MVM Life Science Partners investment in Series C - Momenta Pharmaceuticals
Polaris Partners
Polaris Partners investment in Series C - Momenta Pharmaceuticals
Polaris Partners
Polaris Partners investment in Series B - Momenta Pharmaceuticals
Atlas Venture
Atlas Venture investment in Series B - Momenta Pharmaceuticals
MVM Life Science Partners
MVM Life Science Partners investment in Series B - Momenta Pharmaceuticals
Cardinal Partners
Cardinal Partners investment in Series B - Momenta Pharmaceuticals
Official Site Inspections
http://www.momentapharma.com
- Host name: s3-website-us-east-1.amazonaws.com
- IP address: 16.182.99.229
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
